6USX
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer
Functional Information from GO Data
| Chain | GOid | namespace | contents |
| A | 0003924 | molecular_function | GTPase activity |
| A | 0005525 | molecular_function | GTP binding |
| A | 0007165 | biological_process | signal transduction |
| A | 0016020 | cellular_component | membrane |
| B | 0003924 | molecular_function | GTPase activity |
| B | 0005525 | molecular_function | GTP binding |
| B | 0007165 | biological_process | signal transduction |
| B | 0016020 | cellular_component | membrane |
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 25 |
| Details | binding site for residue GDP A 201 |
| Chain | Residue |
| A | ALA11 |
| A | ASP30 |
| A | GLU31 |
| A | ASN116 |
| A | LYS117 |
| A | ASP119 |
| A | SER145 |
| A | ALA146 |
| A | MG202 |
| A | HOH305 |
| A | HOH307 |
| A | GLY13 |
| A | HOH309 |
| A | HOH314 |
| A | HOH319 |
| A | HOH326 |
| A | HOH327 |
| A | HOH335 |
| A | VAL14 |
| A | GLY15 |
| A | LYS16 |
| A | SER17 |
| A | ALA18 |
| A | PHE28 |
| A | VAL29 |
| site_id | AC2 |
| Number of Residues | 6 |
| Details | binding site for residue MG A 202 |
| Chain | Residue |
| A | SER17 |
| A | GDP201 |
| A | HOH304 |
| A | HOH307 |
| A | HOH309 |
| A | HOH319 |
| site_id | AC3 |
| Number of Residues | 20 |
| Details | binding site for residue M1R A 203 |
| Chain | Residue |
| A | CYS12 |
| A | LYS16 |
| A | PRO34 |
| A | THR58 |
| A | ALA59 |
| A | GLY60 |
| A | GLU62 |
| A | GLU63 |
| A | TYR64 |
| A | ARG68 |
| A | ASP69 |
| A | MET72 |
| A | HIS95 |
| A | TYR96 |
| A | GLN99 |
| A | ILE100 |
| A | VAL103 |
| A | HOH319 |
| B | GLN61 |
| B | TYR64 |
| site_id | AC4 |
| Number of Residues | 23 |
| Details | binding site for residue GDP B 201 |
| Chain | Residue |
| B | GLY13 |
| B | VAL14 |
| B | GLY15 |
| B | LYS16 |
| B | SER17 |
| B | ALA18 |
| B | PHE28 |
| B | VAL29 |
| B | ASP30 |
| B | TYR32 |
| B | ASN116 |
| B | LYS117 |
| B | ASP119 |
| B | LEU120 |
| B | SER145 |
| B | ALA146 |
| B | LYS147 |
| B | MG202 |
| B | M1R203 |
| B | HOH303 |
| B | HOH306 |
| B | HOH316 |
| B | HOH319 |
| site_id | AC5 |
| Number of Residues | 4 |
| Details | binding site for residue MG B 202 |
| Chain | Residue |
| B | SER17 |
| B | GDP201 |
| B | HOH303 |
| B | HOH306 |
| site_id | AC6 |
| Number of Residues | 21 |
| Details | binding site for Di-peptide M1R B 203 and CYS B 12 |
| Chain | Residue |
| A | CYS12 |
| B | ALA11 |
| B | GLY13 |
| B | VAL14 |
| B | LYS16 |
| B | PRO34 |
| B | ALA59 |
| B | GLY60 |
| B | GLU62 |
| B | GLU63 |
| B | TYR64 |
| B | ARG68 |
| B | ASP69 |
| B | MET72 |
| B | HIS95 |
| B | TYR96 |
| B | GLN99 |
| B | ILE100 |
| B | GDP201 |
| B | HOH303 |
| B | HOH331 |
Functional Information from SwissProt/UniProt
| site_id | SWS_FT_FI1 |
| Number of Residues | 16 |
| Details | Motif: {"description":"Effector region"} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI2 |
| Number of Residues | 36 |
| Details | Binding site: {"evidences":[{"source":"PubMed","id":"22431598","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"22566140","evidenceCode":"ECO:0000269"},{"source":"PubMed","id":"34380736","evidenceCode":"ECO:0000305"},{"source":"PubMed","id":"35522713","evidenceCode":"ECO:0000305"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI3 |
| Number of Residues | 2 |
| Details | Modified residue: {"description":"N-acetylmethionine; in GTPase KRas; alternate","evidences":[{"source":"Reference","evidenceCode":"ECO:0000269","citation":{"citationType":"submission","publicationDate":"FEB-2008","submissionDatabase":"UniProtKB","authors":["Bienvenut W.V.","Calvo F.","Kolch W."]}}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI4 |
| Number of Residues | 2 |
| Details | Modified residue: {"description":"N-acetylthreonine; in GTPase KRas, N-terminally processed","evidences":[{"source":"Reference","evidenceCode":"ECO:0000269","citation":{"citationType":"submission","publicationDate":"FEB-2008","submissionDatabase":"UniProtKB","authors":["Bienvenut W.V.","Calvo F.","Kolch W."]}}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI5 |
| Number of Residues | 2 |
| Details | Modified residue: {"description":"N6-acetyllysine","evidences":[{"source":"PubMed","id":"22711838","evidenceCode":"ECO:0000269"}]} |
| Chain | Residue | Details |
| site_id | SWS_FT_FI6 |
| Number of Residues | 2 |
| Details | Glycosylation: {"description":"(Microbial infection) O-linked (Glc) threonine; by P.sordellii toxin TcsL","evidences":[{"source":"PubMed","id":"19744486","evidenceCode":"ECO:0000269"}]} |
| Chain | Residue | Details |
